In-Home Use Study to Evaluate Use of an Intimate Health Product in Females

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Johnson & Johnson Consumer and Personal Products Worldwide
ClinicalTrials.gov Identifier:
NCT00778934
First received: October 23, 2008
Last updated: October 4, 2011
Last verified: October 2011

October 23, 2008
October 4, 2011
December 2007
February 2008   (final data collection date for primary outcome measure)
To assess the effect of product on sexual enhancement by comparing baseline questionnaire responses to the end of study questionnaire responses [ Time Frame: End of study (3 weeks after baseline visit) ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00778934 on ClinicalTrials.gov Archive Site
Safety Assessments will consist of monitoring and recording all non-serious Adverse Events (AEs) and Serious Adverse Events (SAEs), their frequency, severity, seriousness, and relationship to the investigational product. [ Time Frame: throughout duration of the study (+ 30 days for spontaneously reported SAEs) ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
In-Home Use Study to Evaluate Use of an Intimate Health Product in Females
A Single-blind, Multi-center, In-home Use Study to Evaluate Sexual Enhancement Effects of Product PD-F-5394 in Females

The purpose of this study is to evaluate the effects of an intimate health product on sexual experience in females.

Study to evaluate consumer perceptions of a cosmetic intimate health product on sexual experience in females, using a validated psychometric questionnaire.

Interventional
Not Provided
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Single Blind (Subject)
Coitus
Other: Intimate Health Gel
Intimate Health Gel
Other Name: Not marketed yet
Experimental: 1
Intimate Health Gel
Intervention: Other: Intimate Health Gel
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
79
April 2008
February 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Normal, healthy females >18 years of age
  • In committed heterosexual relationship for >6months
  • Of adequate sexual functioning
  • On acceptable method of birth control

Exclusion Criteria:

  • Pregnant or breastfeeding
  • Allergy to product ingredients
  • Irritation or infection in genital area
  • Unstable or uncontrolled medical condition
Female
18 Years and older
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00778934
CA-P-5739-1
No
Johnson & Johnson Consumer and Personal Products Worldwide
Johnson & Johnson Consumer and Personal Products Worldwide
Not Provided
Study Director: Rita Wanser J&J CPPW
Johnson & Johnson Consumer and Personal Products Worldwide
October 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP